Detalles de la búsqueda
1.
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
N Engl J Med
; 389(7): 612-619, 2023 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37585627
2.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 23(10): 1308-1320, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113498
3.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol
; 20(11): 1531-1543, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31540791
4.
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
J Clin Oncol
; : JCO2302445, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759121
5.
Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial.
Adv Radiat Oncol
; 8(1): 101066, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483063
6.
Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer.
J Clin Oncol
; 41(23): 3909-3916, 2023 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37235845
7.
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 770-778, 2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592721
8.
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415.
Int J Radiat Oncol Biol Phys
; 116(1): 39-49, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736921
9.
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys
; 117(2): 370-377, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137444
10.
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.
JCO Clin Cancer Inform
; 6: e2100188, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776901
11.
Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.
J Clin Oncol
; 39(27): 3056-3082, 2021 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279999
12.
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415.
PLoS One
; 16(4): e0249123, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852571
13.
Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer.
Can Urol Assoc J
; 14(4): 122-129, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702551
14.
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 5(5): 664-670, 2019 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30763425
15.
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Radiother Oncol
; 135: 19-24, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31015166
16.
Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial.
Breast Cancer Res Treat
; 110(2): 337-42, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17851756
17.
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 102(2): 287-295, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29913254
18.
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.
Int J Radiat Oncol Biol Phys
; 99(1): 90-93, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28816169
19.
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.
J Clin Oncol
; 35(17): 1884-1890, 2017 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28296582
20.
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate.
J Clin Oncol
; 23(6): 1192-9, 2005 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15718316